rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rachel Meyers

Director

Company insider

Files Form 4 as: Director, Korro Bio.

In numbers

Trades disclosed
5
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
27 Nov 2023
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
KRRO Korro BioDirector · Biotechnology · last 10 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code A—14,677 at $0.00filing
10 Jun 2026filed 11 Jun 2026KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code A—14,677 at $0.00filing
11 Jun 2025filed 12 Jun 2025KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,010 at $0.00filing
11 Jun 2024filed 12 Jun 2024KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code A—5,190 at $0.00filing
27 Nov 2023filed 29 Nov 2023KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code A—12,551 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Jean Francois FormelaDirector · Director at Korro Bio, filing Form 4 there in the last year
Oliver DolanSenior Vice President, Finance · Senior Vice President, Finance at Korro Bio, filing Form 4 there in the last year
Lynx1 Capital Management LP10% owner · 10% owner at Korro Bio, filing Form 4 there in the last year
Ram AiyarPresident and CEO · President and CEO at Korro Bio, filing Form 4 there in the last year
Loic A. VincentChief Scientific Officer · Chief Scientific Officer at Korro Bio, filing Form 4 there in the last year